NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 103 filers reported holding NURIX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,000 | -66.9% | 36,138 | -58.0% | 0.00% | -66.7% |
| Q2 2023 | $859,000 | +5.8% | 85,986 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $812,000 | -11.6% | 91,479 | +9.3% | 0.00% | -25.0% |
| Q4 2022 | $919,000 | -5.6% | 83,715 | +12.0% | 0.00% | 0.0% |
| Q3 2022 | $974,000 | +31.1% | 74,739 | +27.4% | 0.00% | +33.3% |
| Q2 2022 | $743,000 | +23.4% | 58,652 | +36.5% | 0.00% | +50.0% |
| Q1 2022 | $602,000 | -27.7% | 42,955 | +49.2% | 0.00% | -33.3% |
| Q4 2021 | $833,000 | -3.5% | 28,791 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $863,000 | +13.0% | 28,791 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $764,000 | -14.6% | 28,791 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $895,000 | – | 28,791 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $18,210,601 | 1.88% |
| DAFNA Capital Management LLC | 556,695 | $5,561,383 | 1.52% |
| Deep Track Capital, LP | 2,997,830 | $29,948,322 | 1.39% |
| Redmile Group, LLC | 2,857,309 | $28,544,517 | 1.10% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,830,497 | 0.80% |
| Boxer Capital, LLC | 1,224,892 | $12,237 | 0.57% |
| AtonRa Partners | 30,142 | $301,119 | 0.47% |
| Affinity Asset Advisors, LLC | 100,000 | $999,000 | 0.35% |
| HARVARD MANAGEMENT CO INC | 314,762 | $3,144 | 0.31% |
| WASATCH ADVISORS LP | 3,869,775 | $38,659,052 | 0.23% |